Thrombosis

Latest News

Therapeutic-Dose LMWH Cuts Thromboembolism, Deaths in COVID-19

Reduction in venous thromboembolism, arterial thromboembolism, and deaths seen in high-risk patients in non-ICU, but not ICU, settings.

Predictive Performance of Validated VTE Risk Scores in Setting of Malignancy

The clinical performance of several scores to predict VTE risk in the setting of malignancy are compared in a study.

GI Bleeding Increased for New Users of Rivaroxaban

Compared with other DOACs, rivaroxaban linked to higher rates of GI bleeding overall and in an analysis restricted to patients with atrial fibrillation.

D-Dimer Level Not Useful for Ruling Out PE in COVID-19

Overall, 92.3 percent of patients had plasma D-dimer levels ≥0.05 µg/mL, including all with and 91.2 percent without, pulmonary embolism.

Major Bleeding Risk High With Extended AC After First Unprovoked VTE

Long-term risks and consequences are considerable for patients receiving VKA, DOAC after first unprovoked VTE.

Characteristics Associated With Cerebral Venous Thrombosis in MPNs

Researchers characterized incidence and factors linked to cerebral venous thrombosis associated with myeloproliferative neoplasms.

Protein S Deficiency and Thrombosis: Selected Case Studies

The authors review 8 cases of thrombosis in uncommon sites caused by protein S deficiency.

Novel Intracoronary Hypothermia During PCI May Improve Outcomes in Anterior STEMI

This first report on the safety of selective intracoronary hypothermia is a novel therapy that may reduce myocardial reperfusion injury in STEMI that has had demonstrated efficacy in animal model studies.

5 Surprising Cardiovascular Disease Risk Factors Your Patients May Not Know

While cardiovascular disease may be common and commonly known to patients, they may not know some of the surprising factors in their diet and medical history that may actually be putting them at risk. What are some of the cardiovascular disease risk factors patients should know about?

Features of Vaccine-Induced Thrombotic Syndrome Studied

Mortality seen in association with vaccine-induced immune thrombocytopenia and thrombosis (VITT) after the first dose of the ChAdOx1 nCoV-19 vaccine (Oxford-AstraZeneca) is increased for those with cerebral venous sinus thrombosis and a low platelet count.